跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
陳 昌文
副教授
內科學科
前瞻醫療器材科技中心
內科部
電子郵件
cwchen
mail.ncku.edu
tw
h-index
1396
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1992 …
2023
每年研究成果
概覽
指紋
網路
專案
(15)
研究成果
(77)
類似的個人檔案
(6)
指紋
查看啟用 Chang-Wen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Acute Respiratory Distress Syndrome
79%
Breathing
62%
Intensive Care Unit
47%
Microcirculation
44%
Health Care Associated Pneumonia
44%
Lung
35%
Artificial Respiration
34%
Airway Flow
32%
Breathing Mechanics
32%
Community-Acquired Pneumonia
29%
Vasomotion
29%
Asynchrony
24%
Airway Pressure
23%
Continuous Positive Airway Pressure
22%
Smoking Cessation Program
22%
Tidal Volume
22%
Diaphragm
21%
Hemorrhagic Hypotension
19%
Esophagus Pressure
19%
Systolic Blood Pressure
18%
Blood Culture
17%
Retrospective Cohort Study
17%
Lung Lavage
14%
Extubation
14%
Fluid Resuscitation
14%
Acetylcholine
14%
Abstinence
14%
Arterial Pressure
14%
Vasodilatation
14%
Prognostic Factor
14%
Lung Infarction
14%
Blood Flow
14%
Nitric Oxide
14%
Body Weight Gain
14%
Pleura Effusion
14%
Sepsis
14%
Thoracostomy
14%
COVID-19
14%
Prostaglandin
14%
Monocrotaline-Induced Pulmonary Hypertension
14%
Blood Gas
14%
Intubation
14%
Arterial Blood Gas
14%
Venous Blood
14%
Malignant Pleural Effusion
14%
Asthma
14%
Mediastinal Lymphadenopathy
14%
Tracheostomy
14%
Acute Lung Injury
14%
Critical Illness
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
100%
Health Care Associated Pneumonia
44%
Diseases
43%
Community Acquired Pneumonia
38%
Dyspnea
32%
Sepsis
32%
Acetylcholine
29%
Microorganism
29%
Asthma
20%
Lung Edema
19%
Klebsiella
16%
Arginine Methyl Ester
16%
Nitric Oxide
16%
Interleukin 8
15%
Respiratory Failure
14%
Lung Aspergillosis
14%
Arginine
14%
Blood Clotting Factor 10
14%
Lung Infarction
14%
Politef
14%
Interleukin 10
14%
Intubation
14%
Pandemic
14%
Antimicrobial Agent
14%
Chronic Cough
14%
Klebsiella pneumoniae
14%
Lipopolysaccharide
14%
Prostaglandin
14%
Hemodialysis
14%
Gram Negative Bacterium
14%
Tobacco Dependence
14%
Monocrotaline-Induced Pulmonary Hypertension
14%
Coronavirinae
14%
Inflammation
14%
Respiratory Tract Allergy
14%
Critical Illness
14%
Isoniazid
14%
Dose-Response Relationship
14%
Antiinfective Agent
14%
Invasive Aspergillosis
14%
Interleukin 5
14%
Septic Shock
14%
Acute Lung Injury
14%
Clinical Feature
13%
Immobility
12%
Endothelium Derived Relaxing Factor
10%
Heart Disease
10%
Chronic Obstructive Lung Disease
10%
Infectious Agent
9%
Cytokine
8%
Keyphrases
Acute Critical Illness
29%
Healthcare-associated Pneumonia
29%
Pneumonia Patients
24%
Multicenter Retrospective Study
16%
Community-associated
16%
Sepsis-induced Acute Lung Injury
14%
Unplanned Extubation
14%
Reintubation
14%
Scoring Index
14%
Obstructive Ventilatory Defect
14%
COVID-19-associated Pulmonary Aspergillosis
14%
Sauropus Androgynus
14%
Mechanically Ventilated Patients
14%
Fluid Responsiveness
14%
Colonic Inflammation
14%
Acetylcholine
14%
Parapneumonic Empyema
14%
Pressure Reduction
14%
COVID-19 Pandemic
14%
Tracheostomy
14%
Pulmonary Infarction
14%
Real-time Monitoring System
14%
Cardiac Parameters
14%
Pharmacological Modulation
14%
Intensive Care Unit
14%
Respiratory Parameters
14%
Nitric Oxide
14%
Expiratory Phase
14%
Ineffective Triggering
14%
Varicella Pneumonia
14%
Medical Association
14%
Respiratory Mechanics
14%
Drug-resistant Microbes
14%
Flow Deflection
14%
Lipoid
14%
Vasodilation
14%
Acute Pulmonary Edema
14%
Kallistatin
14%
Sepsis Shock
14%
Whole Lung Lavage
14%
Formosan
14%
Pressure Adjustment
14%
Pendelluft
14%
Positive End-expiratory Pressure Titration
14%
Community-acquired Pneumonia
14%
Monocrotaline-induced Pulmonary Hypertension
14%
Blood Flow
14%
Prostaglandins
14%
Blood Gas Parameters
14%
Proportional Assist Ventilation
14%
